...
机译:内皮祖细胞的五年随访捕获支架与冠状动脉损伤风险高的冠状动脉损伤的Paxlitaxel洗脱支架
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Department of CardiologyLeids University Medical CenterLeiden The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Heart Center Academic Medical Center University of AmsterdamAmsterdam The Netherlands;
Genous; percutaneous coronary intervention; restenosis; stent; TAXUS;
机译:内皮祖细胞的五年随访捕获支架与冠状动脉损伤风险高的冠状动脉损伤的Paxlitaxel洗脱支架
机译:初发冠状动脉病变并伴有冠状动脉再狭窄高风险的患者,使用天然内皮祖细胞捕获支架与Taxus Liberte支架进行比较:一项随机,单中心,先导性研究。
机译:佐他莫司和西罗莫司洗脱支架的近期临床疗效。 ENDEAVOR III(美敦力努力药物(ABT-578)洗脱冠状动脉支架系统与赛诺莫司洗脱冠状动脉支架系统在De Novo天然冠状动脉病变中的随机对照试验)的5年随访。
机译:冠状动脉内再狭窄在西罗莫司洗脱支架植入后伴随着嗜酸性粒细胞阳离子蛋白的血浆水平升高
机译:可生物降解的聚合物涂层西罗莫司洗脱冠状动脉支架的临床前和临床评估。
机译:编辑推荐:患有冠心病再狭窄高风险的新生冠状动脉病变患者的Genous™内皮祖细胞捕获支架与TaxusLiberté支架:一项随机单中心先导研究
机译:与具有高再狭窄风险的新生型冠状动脉病变相比,TCT-592在内皮祖细胞捕获支架中的五年事件发生率低于药物洗脱支架;随机对照试验